Vaxxas is focussed on enhancing the performance of existing and next generation vaccines through the development and commercialization of the company's novel vaccine delivery technology - the...
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique...
Australian company Prima BioMed Ltd develops and commercialises technology arising from immunology and cancer immunotherapy.
The company holds commercial rights to technologies developed at the...
BIONOSTRA is a biotechnology company performing breakthrough technology for
the development of biologic vaccines and gene therapy.
The Company uses the many advances made in the fields of...
BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver...
Monogram is a leader in developing and commercializing innovative products to
help guide and improve the treatment of infectious diseases, cancer and other
serious diseases. Our molecular...
Novavax, Inc. is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on drug delivery and biological technologies.
NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument.
NanoSight’s “Nanoparticle Tracking Analysis” (NTA)...
NanoBio® is a biopharmaceutical company focused on developing and commercializing topical and mucosal antimicrobial products derived from its patented NanoStat™ technology platform.
BioSante Pharmaceuticals, Inc. today announced an update on recent developments of its calcium phosphate-based nanotechnology (CAP). Posted February 2 2004
http://www.azonano.com/article.aspx?ArticleID=477 | 5 Feb 2004